Digital Sponsored 4 Questions pharma leaders can’t skip before letting AI act Nataliya Andreychuk explains what teams must do before letting AI act on their behalf, and how that groundwork becomes a competitive advantage.
R&D The reasoning problem In R&D, decisions that matter most rarely happen during the documented steps; they happen in the pauses between them.
Sales & Marketing The new healthcare playbook: Turning workflow into revenue Healthcare organisations aren’t struggling because they lack growth strategies, they’re struggling because they can’t operationalise them.
Sales & Marketing Sponsored Solution Spotlight: iON.AI iON.AI is a powerful, compliance-driven platform purpose-built for Medical Affairs, seamlessly blending human expertise with AI.
Digital Adopting AI platforms: A structured framework for thoughtful... The adoption of AI platforms, particularly in sectors such as drug discovery and healthcare, is a complex and critical process.
R&D 5 strategies for biopharma to optimise patient recruitment i... Patient recruitment remains a significant challenge for biopharma companies, often leading to delays and increased costs in clinical trials.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.